corporate_fare
Neurocrine Switzerland GmbH
- Address
- Hegenheimermattweg 167a
Sponsor Overview
assignment
1
sponsored trial
science
1
molecule
location_city
4
research centres
public
1
country
person_search
3
investigators
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Pharmacokinetics, Safety, and Tolerability of Crinecerfont in Pediatric Patients Aged 0 to <2 Years with Congenital Adrenal Hyperplasia |  Germany | Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 4 sites collaborated multiple times
This sponsor has worked with 4 sites across their trial portfolio.
Therapeutic Focus
- 1.Hormonal diseases1 trial89 other sponsors
Partnered Research Centres
4 centreslocation_city
assignment1047Charite Universitaetsmedizin Berlin KöR
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
location_city
assignment322Universitaetsklinikum Duesseldorf AöR
- Address
- Moorenstrasse 5, Bilk, 40225 Düsseldorf
location_city
assignment662Universitaetsklinikum Heidelberg AöR
- Address
- Im Neuenheimer Feld 410, Neuenheim, 69120 Heidelberg
location_city
assignment486University Hospital Cologne
- Address
- Kerpener Strasse 62, Lindenthal, 50937 Cologne
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Neurocrine Switzerland GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.